Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 99,219 | 81,504 | 65,846 | 71,360 | 44,755 |
| Cost of Goods | 8,685 | 7,492 | 8,830 | 6,905 | 5,503 |
| Gross Profit | 90,534 | 74,012 | 57,016 | 64,455 | 39,252 |
| Operating Expenses | 82,693 | 89,115 | 82,375 | 72,992 | 78,821 |
| Operating Income | 8,526 | -14,611 | -24,529 | -7,632 | -39,066 |
| Interest Expense | 3,071 | 3,029 | 2,982 | 5,551 | 6,653 |
| Other Income | 2,035 | 2,096 | 2,730 | 2,718 | 4,182 |
| Pre-tax Income | 7,490 | -15,544 | -24,781 | -10,465 | -41,537 |
| Income Tax | 80 | 342 | 279 | 323 | N/A |
| Net Income Continuous | 7,410 | -15,886 | -25,060 | -10,788 | -41,537 |
| Net Income | $7,410 | $-15,886 | $-25,060 | $-10,788 | $-41,537 |
| EPS Basic Total Ops | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 |
| EPS Basic Continuous Ops | 0.06 | -0.13 | -0.20 | -0.08 | -0.33 |
| EPS Diluted Total Ops | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 |
| EPS Diluted Continuous Ops | 0.06 | -0.13 | -0.20 | -0.08 | -0.33 |
| EPS Diluted Before Non-Recurring Items | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 |
| EBITDA(a) | $8,537 | $-14,896 | $-22,256 | $-7,775 | $-39,487 |